nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule)
|
Horst Staib, A. |
|
1989 |
87 |
5S1 |
p. S66-S69 4 p. |
artikel |
2 |
An update on the efficacy of ciprofloxacin in animal models of infection
|
Andriole, Vincent T. |
|
1989 |
87 |
5S1 |
p. S32-S34 3 p. |
artikel |
3 |
A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever
|
Bayston, Katherine F. |
|
1989 |
87 |
5S1 |
p. S269-S273 5 p. |
artikel |
4 |
Brief report: Antibiotic prophylaxis in biliary tract surgery
|
Kujath, Peter |
|
1989 |
87 |
5S1 |
p. S255-S257 3 p. |
artikel |
5 |
Brief report: Ciprofloxacin in the treatment of gram-negative bacillary meningitis
|
Schönwald, Slavko |
|
1989 |
87 |
5S1 |
p. S248-S249 2 p. |
artikel |
6 |
Brief report: Ciprofloxacin in the treatment of legionellosis in critically III patients including those cases unresponsive to erythromycin
|
Unertl, Klaus E. |
|
1989 |
87 |
5S1 |
p. S128-S131 4 p. |
artikel |
7 |
Brief report: Ciprofloxacin treatment of sternal wound infections following open heart surgery
|
Soroko, Theresa |
|
1989 |
87 |
5S1 |
p. S240-S242 3 p. |
artikel |
8 |
Brief report: Ciprofloxacin versus ceftazidime in serious infections
|
Reinhardt, John F. |
|
1989 |
87 |
5S1 |
p. S181-S182 2 p. |
artikel |
9 |
Brief report: Clinical study of intravenous and oral ciprofloxacin in complicated bacterial infections
|
Gelfand, Michael S. |
|
1989 |
87 |
5S1 |
p. S235-S237 3 p. |
artikel |
10 |
Brief report: Combination chemotherapy with ciprofloxacin for infection with Mycobacterium tuberculosis in mouse models
|
Chadwick, Maureen |
|
1989 |
87 |
5S1 |
p. S35-S36 2 p. |
artikel |
11 |
Brief report: Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers
|
Deppermann, Karl-Matthias |
|
1989 |
87 |
5S1 |
p. S46-S48 3 p. |
artikel |
12 |
Brief report: Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection
|
Ramirez-Ronda, Carlos H. |
|
1989 |
87 |
5S1 |
p. S195-S197 3 p. |
artikel |
13 |
Brief report: Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitis
|
Canton, Philippe |
|
1989 |
87 |
5S1 |
p. S121-S122 2 p. |
artikel |
14 |
Brief report: Gastrointestinal secretion of ciprofloxacin
|
Sörgel, Fritz |
|
1989 |
87 |
5S1 |
p. S62-S65 4 p. |
artikel |
15 |
Brief report: Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease
|
Heinonen, Penti K. |
|
1989 |
87 |
5S1 |
p. S152-S156 5 p. |
artikel |
16 |
Brief report: Intravenous and oral ciprofloxacin treatment of 52 infections
|
Greenberg, Richard N. |
|
1989 |
87 |
5S1 |
p. S238-S239 2 p. |
artikel |
17 |
Brief report: Intravenous and sequential intravenous and oral ciprofloxacin in the treatment of severe infections
|
Daly, Jennifer S. |
|
1989 |
87 |
5S1 |
p. S232-S234 3 p. |
artikel |
18 |
Brief report: Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery
|
Gombert, Myles E. |
|
1989 |
87 |
5S1 |
p. S250-S251 2 p. |
artikel |
19 |
Brief report: Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration
|
Naber, Kurt G. |
|
1989 |
87 |
5S1 |
p. S57-S59 3 p. |
artikel |
20 |
Brief report: Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery
|
Morran, Christopher |
|
1989 |
87 |
5S1 |
p. S86-S88 3 p. |
artikel |
21 |
Brief report: Prospective, controlled, randomized, non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of severe surgical infections
|
Leal Del Rosal, Pedro |
|
1989 |
87 |
5S1 |
p. S183-S184 2 p. |
artikel |
22 |
Brief report: Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections
|
Dominguez, Judith |
|
1989 |
87 |
5S1 |
p. S136-S137 2 p. |
artikel |
23 |
Brief report: randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia
|
Gangji, Diamon |
|
1989 |
87 |
5S1 |
p. S206-S208 3 p. |
artikel |
24 |
Brief report: Resistance development to fluoroquinolones in Europe
|
Wiedemann, Bernd |
|
1989 |
87 |
5S1 |
p. S9-S11 3 p. |
artikel |
25 |
Brief report: Respiratory tract penetration of ciprofloxacin
|
Reid, Thomas M.S. |
|
1989 |
87 |
5S1 |
p. S60-S61 2 p. |
artikel |
26 |
Brief report: Safety and efficacy of intravenous ciprofloxacin in the treatment of selected infections
|
Abadie-Kemmerly, Sandra |
|
1989 |
87 |
5S1 |
p. S213-S220 8 p. |
artikel |
27 |
Brief report: Safety of ciprofloxacin based on phase IV studies (“Anwendungsbeobachtung”) in the Federal Republic of Germany
|
Reiter, Christoph |
|
1989 |
87 |
5S1 |
p. S103-S106 4 p. |
artikel |
28 |
Brief report: Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections
|
Cox, Clair E. |
|
1989 |
87 |
5S1 |
p. S157-S159 3 p. |
artikel |
29 |
Brief report: Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections
|
Menon, Latha |
|
1989 |
87 |
5S1 |
p. S119-S120 2 p. |
artikel |
30 |
Brief report: Sequential intravenous/oral therapy with ciprofloxacin in severe infection
|
Chrysanthopoulos, Costas J. |
|
1989 |
87 |
5S1 |
p. S225-S227 3 p. |
artikel |
31 |
Brief report: Single-dose preoperative prophylaxis in transurethral surgery
|
Christensen, Mads M. |
|
1989 |
87 |
5S1 |
p. S258-S260 3 p. |
artikel |
32 |
Ciprofloxacin and the fluoroquinolones
|
Fisher, L.Mark |
|
1989 |
87 |
5S1 |
p. S2-S8 7 p. |
artikel |
33 |
Ciprofloxacin-caffeine: A drug interaction established using in vivo and in vitro investigations
|
Harder, Sebastian |
|
1989 |
87 |
5S1 |
p. S89-S91 3 p. |
artikel |
34 |
Ciprofloxacin in combination with other antimicrobials
|
Eliopoulos, George M. |
|
1989 |
87 |
5S1 |
p. S17-S22 6 p. |
artikel |
35 |
Ciprofloxacin in patients with bacteremic infections
|
Bouza, Emilio |
|
1989 |
87 |
5S1 |
p. S228-S231 4 p. |
artikel |
36 |
Ciprofloxacin intravenous dose variance
|
Lode, Hartmut |
|
1989 |
87 |
5S1 |
p. S40-S45 6 p. |
artikel |
37 |
Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections
|
Haddow, Alastair |
|
1989 |
87 |
5S1 |
p. S113-S115 3 p. |
artikel |
38 |
Ciprofloxacin: Major advances in intravenous and oral quinolone therapy
|
Neu, Harold C. |
|
1989 |
87 |
5S1 |
p. S1- 1 p. |
artikel |
39 |
Ciprofloxacin pharmacokinetics in critically III trauma patients
|
Yuen, Geoffrey J. |
|
1989 |
87 |
5S1 |
p. S70-S75 6 p. |
artikel |
40 |
Ciprofloxacin: Toxicologic evaluation of additional safety data
|
Schluter, Gerhard |
|
1989 |
87 |
5S1 |
p. S37-S39 3 p. |
artikel |
41 |
Ciprofloxacin treatment of malignant external otitis
|
Sadé, Jacob |
|
1989 |
87 |
5S1 |
p. S138-S141 4 p. |
artikel |
42 |
Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis
|
Chodosh, Sanford |
|
1989 |
87 |
5S1 |
p. S107-S112 6 p. |
artikel |
43 |
Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery
|
Cox, Clair E. |
|
1989 |
87 |
5S1 |
p. S252-S254 3 p. |
artikel |
44 |
Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection
|
Apuzzio, Joseph J. |
|
1989 |
87 |
5S1 |
p. S148-S151 4 p. |
artikel |
45 |
Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections
|
Gallis, Harry A. |
|
1989 |
87 |
5S1 |
p. S176-S180 5 p. |
artikel |
46 |
Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin
|
Lang, Jean |
|
1989 |
87 |
5S1 |
p. S82-S85 4 p. |
artikel |
47 |
Drug-drug interactions with ciprofloxacin and other fluoroquinolones
|
Polk, Ron E. |
|
1989 |
87 |
5S1 |
p. S76-S81 6 p. |
artikel |
48 |
Effect of the abscess environment on the antimicrobial activity of ciprofloxacin
|
Bryant, Richard E. |
|
1989 |
87 |
5S1 |
p. S23-S27 5 p. |
artikel |
49 |
Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections
|
Kljucar, Sascha |
|
1989 |
87 |
5S1 |
p. S52-S56 5 p. |
artikel |
50 |
Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections
|
Quintero-Perez, Nora P. |
|
1989 |
87 |
5S1 |
p. S198-S201 4 p. |
artikel |
51 |
Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin
|
Crombleholme, William R. |
|
1989 |
87 |
5S1 |
p. S142-S147 6 p. |
artikel |
52 |
Intravenous ciprofloxacin and ceftazidime in serious infections
|
Sifuentes-Osornio, José |
|
1989 |
87 |
5S1 |
p. S202-S205 4 p. |
artikel |
53 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients
|
Kelsey, Stephen M. |
|
1989 |
87 |
5S1 |
p. S274-S277 4 p. |
artikel |
54 |
Intravenous ciprofloxacin for infections in cancer patients
|
Rolston, Kenneth V.I. |
|
1989 |
87 |
5S1 |
p. S261-S265 5 p. |
artikel |
55 |
Intravenous ciprofloxacin or ceftazidime in selected infections
|
Villavicencio, Jorge |
|
1989 |
87 |
5S1 |
p. S191-S194 4 p. |
artikel |
56 |
Intravenous ciprofloxacin therapy in severe infections
|
Gudiol, Francisco |
|
1989 |
87 |
5S1 |
p. S221-S224 4 p. |
artikel |
57 |
Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria
|
Neu, Harold C. |
|
1989 |
87 |
5S1 |
p. S209-S212 4 p. |
artikel |
58 |
Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections
|
Gaut, Paula L. |
|
1989 |
87 |
5S1 |
p. S169-S175 7 p. |
artikel |
59 |
Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections
|
Fass, Robert J. |
|
1989 |
87 |
5S1 |
p. S164-S168 5 p. |
artikel |
60 |
Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure
|
Gentry, Layne O. |
|
1989 |
87 |
5S1 |
p. S132-S135 4 p. |
artikel |
61 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftrazidime plus amikacin for empiric treatment of febrile neutropenic patients
|
Flaherty, John P. |
|
1989 |
87 |
5S1 |
p. S278-S282 5 p. |
artikel |
62 |
New oral and parenteral quinolones
|
Neu, Harold C. |
|
1989 |
87 |
5S1 |
p. S283-S287 5 p. |
artikel |
63 |
Pharmacokinetics of three newer quinolones in pregnant and lactating women
|
Giamarellou, Helen |
|
1989 |
87 |
5S1 |
p. S49-S51 3 p. |
artikel |
64 |
Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections
|
Peacock Jr., James E. |
|
1989 |
87 |
5S1 |
p. S185-S190 6 p. |
artikel |
65 |
Publisher's note
|
|
|
1989 |
87 |
5S1 |
p. iii- 1 p. |
artikel |
66 |
Quinolone resistance
|
Parry, Michael F. |
|
1989 |
87 |
5S1 |
p. S12-S16 5 p. |
artikel |
67 |
Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections
|
Levine, Donald P. |
|
1989 |
87 |
5S1 |
p. S160-S163 4 p. |
artikel |
68 |
Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections
|
Trenholme, Gordon M. |
|
1989 |
87 |
5S1 |
p. S116-S118 3 p. |
artikel |
69 |
Resistance to ciprofloxacin appearing during therapy
|
Chin, Nai-Xun |
|
1989 |
87 |
5S1 |
p. S28-S31 4 p. |
artikel |
70 |
Safety of intravenous ciprofloxacin
|
Arcieri, George M. |
|
1989 |
87 |
5S1 |
p. S92-S97 6 p. |
artikel |
71 |
Safety of oral ciprofloxacin
|
Schacht, Peter |
|
1989 |
87 |
5S1 |
p. S98-S102 5 p. |
artikel |
72 |
Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin
|
Brown, Arthur E. |
|
1989 |
87 |
5S1 |
p. S266-S268 3 p. |
artikel |
73 |
Treatment of serious infections with intravenous ciprofloxacin
|
Modai, Jacques |
|
1989 |
87 |
5S1 |
p. S243-S247 5 p. |
artikel |
74 |
Use of ciprofloxacin in cystic fibrosis patients
|
Bosso, John A. |
|
1989 |
87 |
5S1 |
p. S123-S127 5 p. |
artikel |